Treatment Indications: correction of medium to deep wrinkles and folds (nasolabial folds, glabellar lines, forehead creases, marionette lines);, lip augmentation and contour shaping;, cheek, chin, and zygomatic area volumization, non‑surgical nasal contour refinement;, restoration of facial volume loss and oval definition;, correction of post‑acne scars and tissue depressions
Release form: 1 × 1.0 mL pre‑filled sterile glass syringe
Indications: mid to deep dermal injection for correction of medium to deep wrinkles, folds, and volume deficits;, monophasic gel utilizing SHINE (Stabilized Hyaluronic acid & Improved Novel Efficacy) technology for enhanced gel stability, cohesivity, and even tissue integration with minimal residual BDDE;, providing balanced viscoelasticity, natural‑looking volumetric correction, and minimal migration (effect duration ~9–15 months)